As the Philippines logged 18,528 new Covid-19 cases on Sunday, the utilization of intensive care unit (ICU) beds in Metro Manila decreased from 73 percent to 66 percent.
Also in the capital region, occupied isolation beds for the virus increased by a tad from 62 percent to 63 percent, while the use of mechanical ventilators dropped from 61 to 59 percent.
Those data from the Metro somehow served as rays of hope in an otherwise bleak day as the country had its second-highest daily tally since the pandemic started last year.
The newly-confirmed cases surpassed the previous
second-highest daily count last 23 August of 18,332 cases. On Saturday, the 19,441 new cases stood as the single-day highest so far.
Based on the Department of Health (DoH)’s latest case bulletin, the new cases pushed the total caseload to 1,954,023, of which 143,221 are tagged as active cases.
Of the active cases, 95.3 percent are mild, 2 percent are asymptomatic, 1.1 percent are severe, and 0.6 percent are in critical condition.
The total number of recoveries climbed to 1,777,922 after 17,922 more patients recovered from the dreaded virus.
Meanwhile, the country’s Covid-19 death toll rose to 33,109 after 101 new fatalities were recorded.
The positivity rate stood at 27.9 percent out of the 66,225 individuals who were screened for the respiratory disease on 27 August.
Comparing the data from 28 to 29 August, the country’s ICU beds for Covid-19 has decreased from 74 percent to 71 percent.
The occupied isolation beds for Covid-19 slightly increased from 63 percent to 64 percent, while the mechanical ventilators currently in use also remained at 55 percent.
The DoH noted 205 duplicates were removed from the total case count. Of these, 204 are recoveries.
“Moreover, 38 cases that were previously tagged as recoveries were reclassified as deaths after final validation,” the agency added.
The DoH also added that seven laboratories were not able to submit their data to the Covid-19 Document Repository System.
“Based on data in the last 14 days, the seven non-reporting labs contribute, on average, 2.7 percent of samples tested and 2.1 percent of positive individuals,” it added.